Hypertension Canada's 2020 hypertension guidelines for pharmacists: An update
- PMID: 33598055
- PMCID: PMC7863283
- DOI: 10.1177/1715163520975809
Hypertension Canada's 2020 hypertension guidelines for pharmacists: An update
Conflict of interest statement
Declaration of Conflicting Interests:The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Figures
References
-
- Rabi DM, McBrien KA, Sapir-Pichhadze R, et al. Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment and treatment of hypertension in adults and children. Can J Cardiol 2020;36(5):596-624. - PubMed
-
- Al Hamarneh YN, Hemmelgarn BR, Hassan I, Jones CA, Tsuyuki RT. The effectiveness of pharmacist interventions on cardiovascular risk in adult patients with type 2 diabetes: the multicentre randomized controlled RxEACH trial. Can J Diabetes 2017;41(6):580-6. - PubMed
-
- Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR. The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial. J Am Coll Cardiol 2016;67(24):2846-54. - PubMed
LinkOut - more resources
Full Text Sources